Biomarkers and translational research and precision medicine

8P - First decision impact study of HER2DX in patients (pts) with HER2-positive (HER2+) early breast cancer (ID 228)

Presentation Number
8P
Speakers
  • Olga Martinez Saez (Barcelona, Spain)
Authors
  • Olga Martinez Saez (Barcelona, Spain)
  • Fara Brasó-Maristany (Barcelona, Spain)
  • Mercedes Marín-Aguilera (Barcelona, Spain)
  • Maria Jesus Vidal Losada (Barcelona, Spain)
  • Barbara Adamo (Barcelona, Spain)
  • Tomas Pascual (Barcelona, Spain)
  • Francesco Schettini (Barcelona, Spain)
  • Benedetta Conte (Barcelona, Spain)
  • Nuria Chic (Barcelona, Spain)
  • RAQUEL Gomez Bravo (Barcelona, Spain)
  • Isabel Garcia Fructuoso (Barcelona, Spain)
  • Elia Segui Solis (Barcelona, Spain)
  • Patricia Galván (Barcelona, Spain)
  • Eva Hernández-Illán (Barcelona, Spain)
  • Pedro Jares (Barcelona, Spain)
  • Joan A. Puig-Butille (Barcelona, Spain)
  • Esther Sanfeliu Torres (Barcelona, Spain)
  • Laia Pare Brunet (Barcelona, Spain)
  • Patricia Villagrasa Gonzalez (Barcelona, Spain)
  • Montserrat Munoz (Barcelona, Spain)
Presentation Topic
Biomarkers and translational research and precision medicine